Meanwhile, the immunohistochemistry data of immune markers in the HPA database showed that the level of CD62L (Fig. 8D), a biomarker of naive and memory T cell, was lower in the aneuploid ovarian cancer than the near-diploid group, while the level of CD56 (Fig. 8G), a biomarker of NK cell, was higher than the near-diploid patients. This evidence concerns the gene SELL and ovarian carcinoma.